Par Drugs (India) Price on October 26, 2023

PAR Stock   288.35  4.15  1.42%   
Below is the normalized historical share price chart for Par Drugs And extending back to May 30, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Par Drugs stands at 288.35, as last reported on the 27th of November, with the highest price reaching 294.85 and the lowest price hitting 285.30 during the day.
200 Day MA
242.7506
50 Day MA
260.6474
Beta
0.153
 
Covid
If you're considering investing in Par Stock, it is important to understand the factors that can impact its price. Par Drugs appears to be very steady, given 3 months investment horizon. Par Drugs And maintains Sharpe Ratio (i.e., Efficiency) of 0.0647, which implies the firm had a 0.0647% return per unit of risk over the last 3 months. We have found thirty technical indicators for Par Drugs And, which you can use to evaluate the volatility of the company. Please evaluate Par Drugs' Coefficient Of Variation of 1069.03, risk adjusted performance of 0.0796, and Semi Deviation of 2.06 to confirm if our risk estimates are consistent with your expectations.
  
As of November 27, 2024, Total Stockholder Equity is expected to decline to about 483.9 M. In addition to that, Common Stock Shares Outstanding is expected to decline to about 11.2 M. Par Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0647

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsPAR
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 4.0
  actual daily
35
65% of assets are more volatile

Expected Return

 0.26
  actual daily
5
95% of assets have higher returns

Risk-Adjusted Return

 0.06
  actual daily
5
95% of assets perform better
Based on monthly moving average Par Drugs is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Par Drugs by adding it to a well-diversified portfolio.
Price Book
3.6668
Book Value
78.685
Enterprise Value
3.4 B
Enterprise Value Ebitda
11.9454
Price Sales
3.4024

Par Drugs Valuation on October 26, 2023

It is possible to determine the worth of Par Drugs on a given historical date. On October 26, 2023 Par was worth 198.65 at the beginning of the trading date compared to the closed value of 199.35. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Par Drugs stock. Still, in general, we apply an absolute valuation method to find Par Drugs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Par Drugs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Par Drugs' related companies.
 Open High Low Close Volume
  193.30    205.00    193.30    196.05    16,014  
10/26/2023
  198.65    202.40    190.50    199.35    13,857  
  200.00    204.90    200.00    203.50    5,434  
Backtest Par Drugs  |  Par Drugs History  |  Par Drugs Valuation   PreviousNext  
Open Value
198.65
186.64
Downside
199.35
Closing Value
210.66
Upside

Par Drugs Trading Date Momentum on October 26, 2023

On October 27 2023 Par Drugs And was traded for  203.50  at the closing time. The highest price during the trading period was 204.90  and the lowest recorded bid was listed for  200.00 . The volume for the day was 5.4 K. This history from October 27, 2023 contributed to the next trading day price growth. The trading delta at closing time to the next closing price was 2.08% . The trading delta at closing time to the current price is 9.36% .

Par Drugs And Fundamentals Correlations and Trends

By evaluating Par Drugs' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Par Drugs' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Par financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Par Drugs Stock history

Par Drugs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Par is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Par Drugs And will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Par Drugs stock prices may prove useful in developing a viable investing in Par Drugs
Last ReportedProjected for Next Year
Common Stock Shares Outstanding14.2 M11.2 M
Net Income Applicable To Common Shares106 M65.2 M

Par Drugs Quarterly Net Working Capital

471.85 Million

Par Drugs Stock Technical Analysis

Par Drugs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Par Drugs technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Par Drugs trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Par Drugs Period Price Range

Low
November 27, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Par Drugs And cannot be verified against its exchange. Please verify the symbol is currently traded on National Stock Exchange of India. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Par Drugs November 27, 2024 Market Strength

Market strength indicators help investors to evaluate how Par Drugs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Par Drugs shares will generate the highest return on investment. By undertsting and applying Par Drugs stock market strength indicators, traders can identify Par Drugs And entry and exit signals to maximize returns

Par Drugs Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Par Drugs' price direction in advance. Along with the technical and fundamental analysis of Par Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Par to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for Par Stock analysis

When running Par Drugs' price analysis, check to measure Par Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Par Drugs is operating at the current time. Most of Par Drugs' value examination focuses on studying past and present price action to predict the probability of Par Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Par Drugs' price. Additionally, you may evaluate how the addition of Par Drugs to your portfolios can decrease your overall portfolio volatility.
Stocks Directory
Find actively traded stocks across global markets
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.